High prevalence of acquired HIV drug resistance among gay and bisexual men on antiretroviral therapy in Surabaya, Indonesia: a call for routine genotypic surveillance
Open Access
- 17 September 2025
- journal article
- Published by Salud, Ciencia y Tecnologia in Salud, Ciencia y Tecnología
- Vol. 5, 2190
Abstract
Introduction: HIV affects men who have sex with men (MSM) in a disproportionate way, especially in concentrated epidemics such as Indonesia. Surabaya carries the highest burden among MSM in the country. Yet, evidence on HIV-1 molecular epidemiology and drug resistance is scarce. Methods: A cross-sectional study involved 57 HIV-1–infected gay and bisexual men on antiretroviral therapy (ART) in Surabaya during 2022–2023. Blood samples were taken for HIV-1 pol gene amplification (protease and reverse transcriptase). Sanger sequencing produced subtype data through phylogenetic analysis and RIP. Drug resistance mutations (DRMs) were assessed with IAS-USA 2023 and Stanford HIVdb v10.0. Results: CRF01_AE dominated (82.0%), followed by subtype B (10.5%) and recombinants (7.5%). Sixteen participants had sequences that passed analysis. Five of them (31.3%, 95% CI: 11.8–58.7%) carried major DRMs: K65R (NRTI), K103N (NNRTI), and Q58E/V82A (PI). One case showed resistance to more than one drug class. Overall resistance rates surpassed both regional estimates and the WHO 10% benchmark. Conclusions: See the corresponding section at the end of the paper.Keywords
This publication has 31 references indexed in Scilit:
- The utility of integrating nanopore sequencing into routine HIV-1 drug resistance surveillanceMicrobial Genomics, 2025
- Low HIV drug resistance prevalence among recently diagnosed HIV‐positive men who have sex with men in a setting of high PrEP useJournal of the International AIDS Society, 2024
- Antiretroviral Drug Resistance in HIV Sequences From People Who Inject Drugs and Men Who Have Sex With Men Across 21 Cities in IndiaOpen Forum Infectious Diseases, 2022
- Prevalence of pretreatment HIV drug resistance in key populations: a systematic review and meta‐analysisJournal of the International AIDS Society, 2020
- Prevalence and Transmission Dynamics of HIV-1 Transmitted Drug Resistance in a Southeastern CohortOpen Forum Infectious Diseases, 2018
- High Rates of Transmission of Drug-resistant HIV in Aruba Resulting in Reduced Susceptibility to the WHO Recommended First-line Regimen in Nearly Half of Newly Diagnosed HIV-infected PatientsClinical Infectious Diseases, 2017
- Short Communication: High Prevalence of Transmitted Antiretroviral Drug Resistance Among Newly HIV Type 1 Diagnosed Adults in Mombasa, KenyaAIDS Research and Human Retroviruses, 2012
- The World Health Organization's global strategy for prevention and assessment of HIV drug resistanceAntiviral Therapy, 2008
- Prevalence and determinants of transmitted antiretroviral drug resistance in HIV-1 infectionJournal of Antimicrobial Chemotherapy, 2007
- Antiretroviral-Drug Resistance among Patients Recently Infected with HIVNew England Journal of Medicine, 2002